Piezolith extracorporeal shockwave lithotripsy: the Hotel-Dieu de France experience.
A total of 1500 patients underwent treatment with the Wolf Piezolith 2300 extracorporeal shockwave lithotripter for renal, ureteral, and bladder stones. Follow-up data were available at 3 months for 1435 patients. At that time, the overall stone-free rate was 82.7%: 82.4% for patients with renal stones, 81.0% for those with ureteral stones, and 100% for those with bladder stones. The overall success rate was 92.3%: 93.8% for patients with renal stones, 87.1% for those with ureteral stones, and 100% for those with bladder stones. The auxiliary treatment rate was 14.9%, and the retreatment rate was 53%. The effectiveness quotient was 49.2%. The Wolf Piezolith 2300 is an effective treatment for most stones smaller than 30 mm.
Merhej
S
S
Department of Urology, Hotel-Dieu de France Hospital, Beirut, Lebanon.
Nemr
E
E
Armache
K
K
Chalouhy
E
E
Chaiban
R
R
Moukarzel
M
M
Khoury
R
R
D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D002648:Child; D002675:Child, Preschool; D005260:Female; D005500:Follow-Up Studies; D005602:France; D006761:Hospitals; D006801:Humans; D007669:Kidney Calculi / Q000628:therapy*; D008096:Lithotripsy / Q000295:instrumentation*; D008297:Male; D008875:Middle Aged; D014514:Ureteral Calculi / Q000628:therapy*; D001744:Urinary Bladder Calculi / Q000628:therapy*